Itahisa Marcelino-Rodríguez1, Roberto Elosua2, María del Cristo Rodríguez Pérez1, Daniel Fernández-Bergés3, María Jesús Guembe4, Tomás Vega Alonso5, Francisco Javier Félix6, Delia Almeida González1, Honorato Ortiz-Marrón7, Fernando Rigo8, José Lapetra9, Diana Gavrila10, Antonio Segura11, Montserrat Fitó12, Judith Peñafiel13, Jaume Marrugat13, Antonio Cabrera de León14. 1. Unidad de Investigación de Atención Primaria y del Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España; Red de Investigación Cardiovascular del Instituto Carlos III Institute de Salud, Madrid, España. 2. Red de Investigación Cardiovascular del Instituto Carlos III Institute de Salud, Madrid, España; Grupo de Epidemiología y Genética Cardiovascular, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, España. 3. Unidad de Investigación Don Benito Villanueva, Programa de Investigación Cardiovascular, Fundesalud, Gerencia Área Sanitaria Don Benito-Villanueva, Badajoz, España. 4. Servicio de Docencia y Desarrollo Sanitarios, Grupo de Investigación Riesgo Vascular en Navarra (RIVANA), Departamento de Salud, Gobierno de Navarra, Pamplona, España. 5. Dirección General de Salud Pública e Investigación Desarrollo e Innovación, Consejería de Sanidad de la Junta de Castilla y León, Valladolid, España. 6. Centro de Salud Villanueva Norte, Servicio Extremeño de Salud, Villanueva de la Serena, Badajoz, España. 7. Servicio de Epidemiología. Subdirección General de Promoción de la Salud y Prevención, Servicio Madrileño de Salud, Madrid, España. 8. Grupo Cardiovascular de Baleares de redIAPP, UB Genova, Palma de Mallorca, España. 9. Centro de Salud Universitario "San Pablo", Distrito Sanitario Atención Primaria Sevilla, Servicio Andaluz de Salud, Sevilla, España; CIBER de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, España. 10. Servicio de Epidemiología, Consejería de Sanidad y Consumo de la Región de Murcia, Murcia, España; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, España. 11. Red de Investigación Cardiovascular del Instituto Carlos III Institute de Salud, Madrid, España; Servicio de Investigación, Instituto de Ciencias de la Salud de Castilla-La Mancha, Toledo, Talavera de la Reina, España. 12. Grupo de Riesgo Cardiovascular y Nutrición, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España. 13. Red de Investigación Cardiovascular del Instituto Carlos III Institute de Salud, Madrid, España; Grupo de Epidemiología y Genética Cardiovascular, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España. 14. Red de Investigación Cardiovascular del Instituto Carlos III Institute de Salud, Madrid, España; Grupo de Epidemiología y Genética Cardiovascular, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España; Área de Medicina Preventiva y Salud Pública, Universidad de La Laguna, La Laguna, España. Electronic address: acableo@gobiernodecanarias.org.
Abstract
AIMS: To compare diabetes-related mortality rates and factors associated with this disease in the Canary Islands compared with other 10 Spanish regions. METHODS: In a cross-sectional study of 28,887 participants aged 35-74 years in Spain, data were obtained for diabetes, hypertension, dyslipidemia, obesity, insulin resistance (IR), and metabolic syndrome. Healthcare was measured as awareness, treatment and control of diabetes, dyslipidemia, and hypertension. Standardized mortality rate ratios (SRR) were calculated for the years 1981 to 2011 in the same regions. RESULTS: Diabetes, obesity, and hypertension were more prevalent in people under the age of 64 in the Canary Islands than in Spain. For all ages, metabolic syndrome and insulin resistance (IR) were also more prevalent in those from the Canary Islands. Healthcare parameters were similar in those from the Canary Islands and the rest of Spain. Diabetes-related mortality in the Canary Islands was the highest in Spain since 1981; the maximum SRR was reached in 2011 in men (6.3 versus the region of Madrid; p<0.001) and women (9.5 versus Madrid; p<0.001). Excess mortality was prevalent from the age of 45 years and above. CONCLUSIONS: Diabetes-related mortality is higher in the Canary Islands population than in any other Spanish region. The high mortality and prevalence of IR warrants investigation of the genetic background associated with a higher incidence and poor prognosis for diabetes in this population. The rise in SRR calls for a rapid public health policy response.
AIMS: To compare diabetes-related mortality rates and factors associated with this disease in the Canary Islands compared with other 10 Spanish regions. METHODS: In a cross-sectional study of 28,887 participants aged 35-74 years in Spain, data were obtained for diabetes, hypertension, dyslipidemia, obesity, insulin resistance (IR), and metabolic syndrome. Healthcare was measured as awareness, treatment and control of diabetes, dyslipidemia, and hypertension. Standardized mortality rate ratios (SRR) were calculated for the years 1981 to 2011 in the same regions. RESULTS:Diabetes, obesity, and hypertension were more prevalent in people under the age of 64 in the Canary Islands than in Spain. For all ages, metabolic syndrome and insulin resistance (IR) were also more prevalent in those from the Canary Islands. Healthcare parameters were similar in those from the Canary Islands and the rest of Spain. Diabetes-related mortality in the Canary Islands was the highest in Spain since 1981; the maximum SRR was reached in 2011 in men (6.3 versus the region of Madrid; p<0.001) and women (9.5 versus Madrid; p<0.001). Excess mortality was prevalent from the age of 45 years and above. CONCLUSIONS:Diabetes-related mortality is higher in the Canary Islands population than in any other Spanish region. The high mortality and prevalence of IR warrants investigation of the genetic background associated with a higher incidence and poor prognosis for diabetes in this population. The rise in SRR calls for a rapid public health policy response.
Authors: María Del Cristo Rodríguez Pérez; Chiara Chines; Arturo J Pedrero García; Djeniffer Sousa; Francisco J Cuevas Fernández; Itahisa Marcelino-Rodríguez; Santiago Domínguez Coello; Antonio Cabrera de León Journal: BMC Public Health Date: 2020-01-14 Impact factor: 3.295
Authors: Juan Marco Figueira Gonçalves; José María Hernández Pérez; Marco Acosta Sorensen; Aurelio Luis Wangüemert Pérez; Elena Martín Ruiz de la Rosa; José Luis Trujillo Castilla; David Díaz Pérez; Yolanda Ramallo-Fariña Journal: BMC Res Notes Date: 2020-12-09
Authors: Ana Díaz-de Usera; Luis A Rubio-Rodríguez; Adrián Muñoz-Barrera; Jose M Lorenzo-Salazar; Beatriz Guillen-Guio; David Jáspez; Almudena Corrales; Antonio Íñigo-Campos; Víctor García-Olivares; María Del Cristo Rodríguez Pérez; Itahisa Marcelino-Rodríguez; Antonio Cabrera de León; Rafaela González-Montelongo; Carlos Flores Journal: Sci Rep Date: 2022-09-27 Impact factor: 4.996